Tapestry enters the post-earnings session sharply lower, with a 20% weekly decline having wiped out months of gains following a Q4 print that landed well below the optimism priced in.
The selloff is the dominant fact of this week. TPR closed at $128.98, down more than 20% over the past five sessions, after August 13 earnings results disappointed on guidance. The prior earnings preview had flagged the Street firmly in the bull camp — that conviction has now been tested hard. The stock gave up its entire year-to-date advance in a single session, with the 1-day move registering at -16.1%. That follows a similarly painful print in May, when the stock fell 10.3% on earnings day and extended those losses to -12.5% over the subsequent week. Two consecutive double-digit negative reactions on results days is a pattern worth noting.
Positioning tells an interesting story in the aftermath. Short interest edged up roughly 2% over the week to 8.2% of the free float — a modest rebuild, not a pile-on. Bears added incrementally but have not dramatically accelerated their bets. Borrow conditions remain essentially frictionless: cost-to-borrow has crept up 31% week-on-week but at 0.53% it is still negligible in absolute terms. Availability is extraordinarily loose at over 3,000%, meaning shares available to borrow dwarf those already short by a vast margin — there is no mechanical squeeze pressure here. Options positioning has actually softened: the put/call ratio at 1.06 is running below its 20-day average of 1.15, and the z-score of -1.47 suggests investors were not well-hedged into the miss. That divergence — a stock down 20% on the week but options traders positioned less defensively than usual — reflects a genuine surprise rather than a feared outcome playing out.
The analyst response on August 14 was swift and mixed in direction, though near-unanimous in keeping positive ratings. Morgan Stanley maintained Overweight but trimmed its target from $164 to $159. Wells Fargo held Overweight and cut to $160 from $165. Evercore lowered its Outperform target more aggressively, moving from $175 to $160. Against those cuts, UBS raised its Buy target to $232 from $230, and Barclays lifted its Overweight target to $185 from $182. The result is a Street that still overwhelmingly leans bullish — the mean price target sits at $167, implying roughly 30% upside from current levels — but with a wide spread of targets from $159 to $232 that reflects genuine disagreement about the recovery path. The analyst recommendation differential factor ranks in the 96th percentile, and EPS momentum over the past 30 days sits in the 93rd percentile, suggesting the fundamental picture has not collapsed. The bear case centres on Coach brand concentration risk, Kate Spade's slow recovery, and premium valuation that requires sustained execution — all of which become harder arguments to dismiss after a miss of this magnitude. The trailing P/E has compressed to 15.2x on the week's price action, and EV/EBITDA dropped to 12.3x, a re-rating that may attract value-oriented buyers.
The institutional register offers some context on who was sitting in the stock into the print. BlackRock held 8.9% of shares, with a small addition in the most recent period. State Street added meaningfully — 657,000 shares as of July 31. Boston Partners was the most active buyer in the top-15, adding 2.6 million shares. These are not traders; they are long-duration holders who bought into the bull thesis. Their next reported positions will be the first read on whether the institutional base held or began to rotate following the earnings reaction.
Insider activity through the most recent data (mid-May) shows the CEO sold around $14 million in shares at prices between $133 and $140 — levels very close to where the stock trades today. That selling looked like ordinary estate planning at the time; in hindsight it was well-timed. No insider buying on record to set against those sales.
The next scheduled earnings event is November 5. Between now and then, the questions are less about whether TPR can grow and more about whether management's revised guidance proves conservative or a genuine step-down in trajectory — and whether the Street's still-positive consensus holds as the stock spends time near these lower levels.
See the live data behind this article on ORTEX.
Open TPR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
